Contralateral Parotid-Sparing Radiotherapy in Patients with Unilateral Squamous Cell Carcinoma of the Head and Neck: Technical Methodology and Preliminary Results
Authors:
- 1 January 2004
- journal article
- other
- Published by SAGE Publications in Tumori Journal
- Vol. 90 (1) , 66-72
Abstract
Aims and background: Radiation-induced permanent xerostomia occurs frequently in patients affected by squamous cell carcinoma of the head and neck treated by parallel opposed lateral fields. An ipsilateral technique by using co-planar multiple-field arrangement was designed to restrict treatment to the primary tumor and neck on the same side for patients with selected lateralized squamous cell carcinoma of the head and neck. Methods: From November 2001 till December 2002, 30 patients affected by squamous cell carcinoma of tonsillar fossa, retro-molar trigone, alveolar ridge and oropharyngeal lateral wall were included in this investigational trial and treated with an ipsilateral multiple field technique: in detail, oblique opposed two upper half fields were planned ipsilaterally to the squamous cell carcinoma site to cover PTV1 and PTV2, whereas an anterior-lower half field was planned to encompass the lower neck node area above clavicles. On CT scans, the contralateral parotid gland was outlined as organ at risk and the contralateral upper lymph node area was contoured as volume of interest. In selected cases, convergent oblique two wedge-pair half fields were added to opposed oblique two-field technique in order to cover only PTV2: generally, in these patients, PTV1 received 1.8 Gy per fraction and PTV2 2.2 Gy per fraction up to total doses of 54 Gy and 66 Gy, respectively. Results: Ten patients received radical radiotherapy, 9 patients radical alternating chemo-radiotherapy, and 11 patients adjuvant radiotherapy. At the end of treatment, unilateral confluent mucositis was recorded in 13 (43%) patients and unilateral moist skin epidermolysis in 14 (46%) patients. Six months after the end of radiotherapy, grade 0 xerostomia was recorded in 20 (67%) patients. No patient experienced grade 2+ xerostomia. At a median follow-up of 12 months, 26 (86%) patients were alive and well; 2 patients (6%) developed contralateral neck node failure, both 4 months after the end of ipsilateral radiotherapy. Conclusions: These results, although preliminary, suggest that by using an ipsilateral radiotherapy technique, symptomatic xerostomia may be avoided in selected patients with lateralized squamous cell carcinoma of the head and neck without an increased short-term risk of contralateral nodal failure.Keywords
This publication has 20 references indexed in Scilit:
- Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neckCancer, 2001
- The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar regionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Sélection et délimitation des volumes–cibles anatomocliniques ganglionnaires dans les tumeurs de la sphère cervico-maxillo-facialeCancer/Radiothérapie, 2001
- Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- The Use and Misuse of Neck Dissection for Head and Neck CancerJournal of the American College of Surgeons, 2001
- On the Delineation of the Gross Tumor Volume and Clinical Target Volume for Head and Neck Squamous Cell CarcinomasTumori Journal, 2001
- Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experienceRadiotherapy and Oncology, 2000
- Ipsilateral irradiation for carcinomas of tonsillar region and soft palate based on computed tomographic simulationRadiotherapy and Oncology, 2000
- The early changes in salivary gland function during and after radiotherapy given for head and neck cancerRadiotherapy and Oncology, 1994
- The risk of contralateral lymphatic metastases for cancers of the larynx and pharynxAmerican Journal of Otolaryngology, 1992